MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 Oregon Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Oregon cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Multiple sclerosis drugs by 2026 Oregon Part D plan
DrugWellcare Classic$0.00/moS4802-020Wellcare Value Script$0.00/moS4802-135HealthSpring Assurance Rx$0.00/moS5617-148Humana Basic Rx Plan$0.00/moS5884-113Humana Value Rx Plan$22.10/moS5884-209AARP Medicare Rx Saver from UHC$38.40/moS5921-374HealthSpring Extra Rx$50.00/moS5617-380SilverScript Choice$85.90/moS5601-060Humana Premier Rx Plan$108.60/moS5884-176AARP Medicare Rx Preferred from UHC$110.00/moS5921-411
KesimptaofatumumabNot coveredNot coveredTier 5PA25%QL 1.6/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
teriflunomidegeneric AubagioTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA33%QL 30/30dTier 4PA33%QL 30/30dNot coveredNot coveredTier 5PA25%QL 30/30dTier 4PA50%QL 30/30dTier 437%QL 30/30d
dimethyl fumarategeneric TecfideraTier 4PA28%QL 56/28dTier 4PA40%QL 56/28dTier 4PA30%QL 14/30dNot coveredNot coveredTier 436%QL 56/28dTier 4PA30%QL 14/30dNot coveredTier 4PA50%QL 14/30dTier 437%QL 56/28d
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
fingolimodgeneric GilenyaTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dNot coveredTier 3PA25%QL 30/30dTier 3PA20%QL 30/30dTier 436%QL 30/30dNot coveredTier 5PA25%QL 30/30dTier 3PA$45.00QL 30/30dTier 437%QL 30/30d
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.